Caspase-1–deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis
- 1 December 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (6), 2202-2213
- https://doi.org/10.1111/j.1523-1755.2004.66010.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Possible Involvement of Oxidative Stress in Cisplatin-Induced Apoptosis in LLC-PK1 CellsJournal of Toxicology and Environmental Health, Part A, 2003
- Correlation of renal tubular epithelial cell–derived interleukin‐18 up‐regulation with disease activity in MRL‐Faslpr mice with autoimmune lupus nephritisArthritis & Rheumatism, 2002
- Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent PathwaysJournal of Pharmacology and Experimental Therapeutics, 2002
- Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injuryKidney International, 2001
- Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cellsKidney International, 2001
- IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursorJournal of Clinical Investigation, 1999
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting EnzymeScience, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- Assessment of myeloperoxidase activity in whole rat kidneyJournal of Pharmacological Methods, 1990